Antipsychotic | World of Psychology

Antipsychotic Articles

10 Ways to Manage Your Weight on Psych Meds

Thursday, June 18th, 2009

Awhile back, a Beyond Blue reader asked me to address the problem of weight gain and medication. "How do you deal ...

Read more... »

9 Myths of Bipolar Disorder

Friday, June 12th, 2009

Bipolar disorder has been the focus of attention in recent years, as a new slew of psychiatric medications have ...

Read more... »

What if your new drug has an unwanted side effect that's going to impact sales if it becomes widely known? Well, in the case of Abilify (aripiprazole) apparently, you make that side effect's data difficult ...

Read more... »

Surprise Approval of Fanapt Makes Stock Go Wild

Thursday, May 7th, 2009

Shares of Vanda Pharmaceuticals, the makers of Fanapt (iloperidone), surged today after the U.S. Food and Drug Administration sprang a surprise drug approval for Fanapt for schizophrenia late yesterday. In afternoon trading today, the stock hit ...

Read more... »

Zyprexa Redux

Thursday, February 12th, 2009

If you haven't been hiding under a rock in the past few years, you've probably heard about Zyprexa (olanzapine). It's an atypical antipsychotic psychiatric medication used first to treat schizophrenia, then extended to include the ...

Read more... »

Antipsychotic Use in Elderly, Alzheimer’s

Friday, January 9th, 2009

A rebuke to years of off-label marketing by pharmaceutical companies behind closed doctors' doors was just published in the form of a journal article demonstrating that the use of atypical antipsychotic medications significantly increase the ...

Read more... »

FDA Advisors: Stop the Overuse of Atypical Antipsychotics in Children

Wednesday, November 19th, 2008

During a routine review of the safety of Johnson & Johnson's atypical antipsychotic Risperdal and Eli Lilly’s Zyprexa, a panel of experts consulting with the U.S. Food and Drug Administration (FDA) expressed their concern for ...

Read more... »

Did Eli Lilly Downplay Zyprexa’s Health Risks?

Sunday, September 7th, 2008

A New York City federal judge ordered drug company Eli Lilly to unseal confidential documents concerning the popular antipsychotic drug Zyprexa (Olanzapine) this past Friday, after a lengthy legal dispute. Yesterday’s New York ...

Read more... »

Psychiatrists, MDs Ignore CATIE, Keep Prescribing Atypicals

Saturday, August 9th, 2008

My old hometown newspaper, The News Journal (Wilmington, Del.) had a nice write-up of Seroquel's big explosion in prescriptions over the past decade. Seroquel is made by one ...

Read more... »

Treating Bipolar Disorder in Children

Wednesday, July 30th, 2008

A letter to the editor in today's The Boston Globe by Janet Wozniak suggests that since the U.S. Food and Drug Administration (FDA) approved the use of two atypical antipsychotic medications last year for ...

Read more... »

Older Antipsychotics Get Warning Too

Tuesday, June 17th, 2008

I'm not real sure why this was making headlines yesterday, but apparently the fact that the FDA required a black box warning on older antipsychotic medications was news on a slow news day. Here's why ...

Read more... »

The Atypical Antipsychotic War

Monday, April 14th, 2008

Robert Farley of the St. Petersburg Times had an excellent in-depth piece about the war to increase prescriptions of atypical antipsychotics in America. I say "war," because it really seems like there was a concerted, ...

Read more... »